| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |